Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster
Sakshi Jasra, Orsi Giricz, Rachel Zeig‐Owens, Kith Pradhan, David G. Goldfarb, Angelica Barreto-Galvez, Alexander J. Silver, Jiahao Chen, Srabani Sahu, Shanisha Gordon-Mitchell, Gaurav S. Choudhary, Srinivas Aluri, Tushar D. Bhagat, Aditi Shastri, Adrian Bejan, Shannon Stockton, Travis Spaulding, Victor Thiruthuvanathan, Hiroki Goto, Jeannine Gerhardt, Syed Hissam Haider, Arul Veerappan, Matthias Bartenstein, George Nwankwo, Ola Landgren, Michael D. Weiden, Jacqueline K. Lekostaj, Ryan Bender, Frederick A. Fletcher, Lee M. Greenberger, Benjamin L. Ebert, Ulrich Steidl, Britta Will, Anna Nolan, Advaitha Madireddy, Michael R. Savona, David J. Prezant, Amit Verma (2022). High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. Nature Medicine, 28(3), pp. 468-471, DOI: 10.1038/s41591-022-01708-3.
Article357 days agoFinal analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
Saad Z. Usmani, Hang Quach, María‐Victoria Mateos, Ola Landgren, Xavier Leleu, David S. Siegel, Katja Weisel, Xiaomei Shu, Chuang Li, Meletios A Dimopoulos (2023). Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study. , 7(14), DOI: https://doi.org/10.1182/bloodadvances.2023010026.
Article37 days agoCarfilzomib, Daratumumab, and Dexamethasone (KdD) Vs Carfilzomib and Dexamethasone (Kd) for Relapsed/Refractory Multiple Myeloma (RRMM) in the Phase 3 Candor Study: Subgroup Analysis According to Renal Functioning
Meletios A Dimopoulos, Ola Landgren, David S. Siegel, Sebastian Grosicki, Albert Oriol, Rani Najdi, Chuang Li, Khalid Mezzi, Natalie Shu, Hang Quach (2023). Carfilzomib, Daratumumab, and Dexamethasone (KdD) Vs Carfilzomib and Dexamethasone (Kd) for Relapsed/Refractory Multiple Myeloma (RRMM) in the Phase 3 Candor Study: Subgroup Analysis According to Renal Functioning. , 142(Supplement 1), DOI: https://doi.org/10.1182/blood-2023-190726.
Article37 days agoWaldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations
Kylee Maclachlan, Tina Bagratuni, Efstathios Kastritis, Bachisio Ziccheddu, Sydney X. Lu, Venkata Yellapantula, Chris Famulare, Kimon V. Argyropoulos, Andriy Derkach, Elli Papaemmanuil, Ahmet Doǧan, Alexander M. Lesokhin, Saad Z. Usmani, Ola Landgren, Lia Palomba, Francesco Maura, Meletios A Dimopoulos (2022). Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations. , 7(6), DOI: https://doi.org/10.1182/bloodadvances.2022008876.
Article37 days agoThe Genomic Landscape of Waldenström Macroglobulinemia Reveals Sustained Germinal Center Activity and Late-Developing Copy Number Aberrations
Kylee Maclachlan, Tina Bagratuni, Efstathios Kastritis, Bachisio Ziccheddu, Sydney X. Lu, Venkata D. Yellapantula, Christopher Famulare, Benjamin Diamond, Monika Chojnacka, Arjun Raj, Emilia Mason, David G. Coffey, James E. Hoffman, Dickran Kazandjian, Andriy Derkach, Elli Papaemmanuil, Ahmet Doǧan, Alexander M. Lesokhin, Ola Landgren, M. Lia Palomba, Francesco Maura, Meletios A Dimopoulos (2021). The Genomic Landscape of Waldenström Macroglobulinemia Reveals Sustained Germinal Center Activity and Late-Developing Copy Number Aberrations. , 138(Supplement 1), DOI: https://doi.org/10.1182/blood-2021-148095.
Article37 days ago